Experimental Weight Loss Drug Delivers Dramatic 28% Body Weight Reduction in Clinical Trial
Eli Lilly's retatrutide injection shows results comparable to gastric bypass surgery among heaviest patients after 80 weeks of treatment.
Read the full reporting at NYT.
Originally reported by NYT.